The article published by Narumi et al. is important as they reveal a connection between
fat-free mass index (FFMI) and cardiac prognosis in cardiac failure patients [
[1]
]. However, we think that there are some problems about the methodology used in FFMI
evaluation.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure.Eur J Intern Med. 2015; 26: 118-122
- Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people.Age Aging. 2010; 39: 412-423
Article info
Publication history
Published online: June 05, 2015
Accepted:
May 21,
2015
Received:
May 20,
2015
Identification
Copyright
© 2015 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
